# Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes

> **NCT07695727** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 84 (estimated)

## Conditions studied

- Type 1 Diabetes
- Autoimmunity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07695727
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-09
- **Final completion:** 2029-09
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695727, "Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07695727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*